Gale E Smith

Title: Gale E. Smith: Innovator in Vaccine Technology

Introduction

Gale E. Smith is a notable inventor based in Bryan, TX (US), recognized for his contributions to vaccine technology. With a total of 3 patents, he has made significant strides in enhancing vaccine stability and immunogenicity.

Latest Patents

One of his latest patents focuses on vaccine compositions that have improved stability and immunogenicity. This innovation involves nanoparticles that present antigens from pathogens, surrounded by a detergent core, resulting in enhanced stability and good immunogenicity. The patent also discloses dosages, formulations, and methods for preparing these vaccines and nanoparticles. Another significant patent is a method for producing a recombinant baculovirus expression vector. This method allows for the expression of a selected gene in a host insect cell by cleaving baculovirus DNA to produce a DNA fragment that includes a polyhedrin gene or portion thereof. The process involves preparing a recombinant transfer vector and using it to infect susceptible insects or cultured insect cells, leading to the production of the protein product from the incorporated selected gene.

Career Highlights

Gale E. Smith is affiliated with The Texas A&M University System, where he continues to contribute to research and innovation in the field of biotechnology. His work has implications for vaccine development and production, showcasing his commitment to advancing public health.

Collaborations

Some of his notable coworkers include Max D. Summers and Ye Liu, who collaborate with him on various research projects.

Conclusion

Gale E. Smith's innovative work in vaccine technology and his contributions to the field through his patents highlight his role as a significant inventor. His research continues to pave the way for advancements in vaccine stability and efficacy.